Alternative Sentencing Policies for Drug Offenders: Evaluating the Effectiveness of Kansas Senate Bill 123, 2001-2010 (ICPSR 30982)
The study examined the first five years of operation of Kansas senate bill 123 (November 2003-November 2008) examining individual-level and system-level outcomes over time and across community corrections districts and judicial actors. The study also assesses the impact of SB 123 on the work routines of criminal justice system actors, examining changes in sentencing and supervision practices and interactions across agencies following the implementation of SB 123.
Individual-level impacts of SB 123 on recidivism rates are assessed using sentencing and revocation data collected by the Kansas Sentencing Commission for drug possessors sentenced in Kansas between November 1, 2001 and October 31, 2008 (Dataset 1). Propensity score matching was used to compare the revocation and reconviction rates of drug possessors sentenced to SB 123 with the recidivism rates of similar individuals sentenced to regular probation (standard supervision by community corrections or court services) (Dataset 2). Supervision and program participation data provided by the Kansas Department of Corrections were used to assess the use of drug treatment services, education and employment services, and sanctions for individuals sentenced to SB 123 or standard community corrections (Dataset 3). These quantitative data were complemented by a set qualitative data derived from interviews with SB 123-eligible offenders (Dataset 4), community corrections managers, and courtroom actors (judges, prosecutors, public defenders) (Dataset 5).
Census of Juveniles in Residential Placement and Juvenile Residential Facility Census, 1997-2010 -- Concatenated Matched Data [United States] (ICPSR 27543)
Census of Juveniles in Residential Placement and Juvenile Residential Facility Census, 1997-2010 -- Concatenated Matched Facility-Level Data [United States] (ICPSR 27544)
Census of Juveniles in Residential Placement and Juvenile Residential Facility Census, 1997-2010 -- Concatenated Matched State-Level Data [United States] (ICPSR 27545)
Criminal Histories and Criminal Justice Processing of Drug Use Forecasting (DUF) Sample Members in Washington, DC, 1989-1991 (ICPSR 6122)
Differences in the Validity of Self-Reported Drug Use Across Five Factors in Indianapolis, Fort Lauderdale, Phoenix, and Dallas, 1994 (ICPSR 2706)
Drug Use Forecasting in 24 Cities in the United States, 1987-1997 (ICPSR 9477)
Estimating the Elasticities of Demand for Cocaine and Heroin with Data from 21 Cities from the Drug Use Forecasting (DUF) Program, 1987-1991 (ICPSR 6567)
Monitoring Drug Markets in Manhattan [New York City], With the Arrestee Drug Abuse Monitoring (ADAM) Program, 1998-2002 (ICPSR 22381)
Multi-Site Adult Drug Court Evaluation (MADCE), 2003-2009 (ICPSR 30983)
The Multi-Site Adult Drug Court Evaluation (MADCE) study included 23 drug courts and 6 comparison sites selected from 8 states across the country. The purpose of the study was to: (1) Test whether drug courts reduce drug use, crime, and multiple other problems associated with drug abuse, in comparision with similar offenders not exposed to drug courts, (2) address how drug courts work and for whom by isolating key individual and program factors that make drug courts more or less effective in achieving their desired outcomes, (3) explain how offender attitudes and behaviors change when they are exposed to drug courts and how these changes help explain the effectiveness of drug court programs, and (4) examine whether drug courts generate cost savings.
Offenders in all 29 sites were surveyed in 3 waves, at baseline, 6 months later, and 18 months after enrollment. The research comprises three major components: process evaluation, impact evaluation, and a cost-benefit analysis. The process evaluation describes how the 23 drug court sites vary in program eligibility, supervision, treatment, team collaboration, and other key policies and practices. The impact evaluation examines whether drug courts produce better outcomes than comparison sites and tests which court policies and offender attitudes might explain those effects. The cost-benefit analysis evaluates drug court costs and benefits.